Alpharma, Shasun ink generic drug pact

New Jersey-based Alpharma will provide development funding to India's Shasun Chemicals as part of a marketing pact to distribute generic drugs in the US and Europe. Shasun will manufacture 10 generic drugs for a variety of conditions -- including cardiovascular conditions -- with a cumulative market value of $20 billion.

- read this article from the Business-Standard for more